IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

IOL Chemicals & Pharmaceuticals Ltd

₹ 434 1.50%
03 Jul - close price
iolcp.com BSE: 524164 NSE: IOLCP
About

IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market.[1]

It is the largest player of Ibuprofen (pain killer) globally with a world market share of 35%.[2]

Key Points

Largest Producer of Ibuprofen
It is the largest producer of Ibuprofen (12000 TPA) and the only company worldwide being backward integrated with ~35% Global share. It is the largest producer of Ethyl Acetate at Single Location in India and also 2nd largest producer of Iso Butyl Benzene (IBB) with ~30% Global share. [1]

Website BSE NSE
  • Market Cap ₹ 2,545 Cr.
  • Current Price ₹ 434
  • High / Low ₹ 536 / 331
  • Stock P/E 18.9
  • Book Value ₹ 275
  • Dividend Yield 1.15 %
  • ROCE 12.2 %
  • ROE 8.62 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 17.6%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
572 565 541 523 587 563 545 520 504
527 509 510 481 492 491 481 476 454
Operating Profit 45 56 32 43 95 73 64 44 50
OPM % 8% 10% 6% 8% 16% 13% 12% 9% 10%
7 5 5 7 9 7 7 8 8
Interest 2 3 4 5 5 4 4 4 3
Depreciation 11 11 11 12 12 14 16 16 16
Profit before tax 39 47 22 33 87 61 51 32 37
Tax % 23% 26% 28% 28% 26% 25% 26% 28% 26%
30 35 16 24 65 46 38 23 28
EPS in Rs 5.07 5.91 2.71 4.05 11.03 7.81 6.45 3.93 4.70
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
2,184 2,217 2,133
1,925 1,991 1,902
Operating Profit 259 226 231
OPM % 12% 10% 11%
17 25 30
Interest 8 16 16
Depreciation 43 46 63
Profit before tax 225 189 182
Tax % 25% 26% 26%
168 139 134
EPS in Rs 28.56 23.70 22.90
Dividend Payout % 14% 17% 22%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -4%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -4%
Stock Price CAGR
10 Years: 24%
5 Years: 16%
3 Years: -13%
1 Year: 15%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Equity Capital 59 59 59
Reserves 1,334 1,449 1,553
44 80 33
526 435 600
Total Liabilities 1,962 2,022 2,244
561 752 934
CWIP 105 90 100
Investments 2 20 20
1,294 1,161 1,190
Total Assets 1,962 2,022 2,244

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
93 122 290
-121 -120 -191
-2 -4 -92
Net Cash Flow -29 -2 6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Debtor Days 79 83 81
Inventory Days 95 77 111
Days Payable 95 74 123
Cash Conversion Cycle 79 86 69
Working Capital Days 78 86 77
ROCE % 14%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
43.69% 43.69% 43.69% 43.69% 43.69% 43.69% 43.69% 48.19% 48.19% 48.19% 48.19% 48.19%
5.05% 2.76% 3.03% 3.14% 2.50% 2.41% 2.37% 2.43% 3.54% 2.33% 2.18% 1.40%
0.04% 0.36% 0.51% 0.04% 0.04% 0.05% 0.16% 0.23% 0.25% 0.35% 0.36% 0.29%
51.21% 53.18% 52.77% 53.13% 53.77% 53.84% 53.78% 49.15% 48.02% 49.12% 49.27% 50.11%
No. of Shareholders 1,27,8931,42,0221,45,0411,46,4371,48,9071,45,6921,43,3271,40,1771,26,0041,35,3971,34,2351,30,003

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls